APOC3 and metabolic dysfunction-associated steatotic liver disease: A prospective case–control study suggested that APOC3 (−455 T > C) genetic variation was involved in the susceptibility to developing nonalcoholic fatty liver disease, insulin resistance, hypertension, hypertriglyceridemia, and low HDL in the Southern Chinese Han population [28].